Caitong International Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.9K Buy
67,629
+58,468
+638% +$110K 0.02% 625
2025
Q4
$21.9K Buy
+9,161
New +$25.1K 0.01% 965

Other funds holding HCAT

Caitong International Asset Management's HCAT Position: Q1 2026 in Review

Caitong International Asset Management increased its Health Catalyst (HCAT) stake by 638% in Q1 2026, buying an estimated $110K and bringing the position to 67,629 shares worth $85.9K. The position accounts for 0.02% of the portfolio, ranked #625.

Caitong International Asset Management first reported a position in HCAT in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Caitong International Asset Management held 67,629 shares of Health Catalyst worth $85.9K as of Q1 2026.
  • Caitong International Asset Management bought 58,468 Health Catalyst shares in Q1 2026, an estimated $110K.
  • Health Catalyst made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #625 holding.
  • Caitong International Asset Management first reported a position in Health Catalyst in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.